A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

被引：0
|
作者：
Nong Xu
Xiao Chen Zhang
Jian Ping Xiong
Wei Jia Fang
Lan Fang Yu
Jiong Qian
Ling Zhang
机构：
[1] Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
[2] Nanchang University,Department of Oncology, The First Affiliated Hospital
来源：
BMC Cancer | / 7卷
关键词：
Bone Metastasis; Carboplatin; Transitional Cell Carcinoma; Overall Response Rate; Eastern Cooperative Oncology Group Performance Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Phase I trial of paclitaxel, cisplatin, and gemcitabine (TCG) in patients (p) with advanced transitional cell carcinoma (TCC) of the urothelium
    Bellmunt, J
    Baselga, J
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 140 - 140
  • [22] Phase I trial of paclitaxel/carboplatin in advanced carcinoma of the urothelium
    Vaughn, DJ
    Malkowicz, SB
    Zoltick, B
    Ramchandani, P
    Tonkonow, B
    Armstead, B
    Wein, A
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S47 - S50
  • [23] Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: A phase II Hoosier Oncology Group Study
    Li, JX
    Juliar, B
    Yiannoutsos, C
    Ansari, R
    Fox, E
    Fisch, MJ
    Einhorn, LH
    Sweeney, CJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1185 - 1191
  • [24] CARBOPLATIN AND GEMCITABINE IN ELDERLY AND/OR FRAIL PATIENTS (PTS) WITH ADVANCED TRANSITIONAL CELL CARCINOMA (TCC): A PHASE II STUDY
    Baitar, A.
    De Vos, M.
    Vandebroek, A.
    Schrijvers, D.
    ANNALS OF ONCOLOGY, 2010, 21 : 281 - 281
  • [25] Gemcitabine plus carboplatin in recurrent and advanced breast cancer: A phase II trial.
    Silva, JA
    Michel, LMP
    Rincon, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 95S - 95S
  • [26] Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature
    Hudson, E.
    Lester, J. F.
    EUROPEAN JOURNAL OF CANCER CARE, 2010, 19 (03) : 324 - 328
  • [27] Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium
    Lorusso, V
    Crucitta, E
    Silvestris, N
    Rosati, G
    Manzione, L
    De Lena, M
    ONCOLOGY REPORTS, 2005, 13 (02) : 283 - 287
  • [28] Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): A phase II multicenter trial
    Mancarella, S
    Lorusso, V
    Manzione, L
    Antimi, M
    De Vita, F
    Santoro, A
    Maiorino, L
    Mattioli, R
    Luporini, G
    Bilancia, D
    De Lena, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S347 - S348
  • [29] Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer
    Wille, AH
    Johannsen, M
    Roigas, J
    Schnorr, DR
    JOURNAL OF UROLOGY, 2003, 169 (04): : 380 - 381
  • [30] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder
    Smith, David C.
    Mackler, Niklas J.
    Dunn, Rodney L.
    Hussain, Maha
    Wood, David
    Lee, Cheryl T.
    Sanda, Martin
    Vaishampayan, Ulka
    Petrylak, Daniel P.
    Quinn, David I.
    Beekman, Kathleen
    Montie, James E.
    JOURNAL OF UROLOGY, 2008, 180 (06): : 2384 - 2388
12345